IOVANCE BIOTHERAPEUTICS, INC. (IOVA) /
The debt of IOVANCE BIOTHERAPEUTICS, INC. over the past 10 years
Chart IOVANCE BIOTHERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, IOVANCE BIOTHERAPEUTICS, INC. had liquid cash of $296.98M and total debt of $1M: net cash of $295.98M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2021 ($1M) and lowest at the end of fiscal 2016 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $296.98M* | $1M | $295.98M |
| 2024ended Dec 31, 2024 | $323.78M* | $1M | $322.78M |
| 2023ended Dec 31, 2023 | $279.87M* | $1M | $278.87M |
| 2022ended Dec 31, 2022 | $471.85M* | $1M | $470.85M |
| 2021ended Dec 31, 2021 | $504.41M* | $1M | $503.41M |
| 2020ended Dec 31, 2020 | $629.44M* | $0 | $629.44M |
| 2019ended Dec 31, 2019 | $307.08M* | $0 | $307.08M |
| 2018ended Dec 31, 2018 | $468.52M* | $0 | $468.52M |
| 2017ended Dec 31, 2017 | $145.37M* | $0 | $145.37M |
| 2016ended Dec 31, 2016 | $166.47M* | $0 | $166.47M |
Fiscal years as IOVANCE BIOTHERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IOVANCE BIOTHERAPEUTICS, INC.
- The revenue of IOVANCE BIOTHERAPEUTICS, INC.
- The profitability of IOVANCE BIOTHERAPEUTICS, INC.
- The cash flow of IOVANCE BIOTHERAPEUTICS, INC.
- All of IOVANCE BIOTHERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- SMGScotts Miracle-Gro Co
- COCOThe Vita Coco Company, Inc.
- CNRCore Natural Resources, Inc.
- AZZAZZ Inc.
- KGSKodiak Gas Services, Inc.
Not investment advice. This page shows what IOVANCE BIOTHERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.